首页> 外文期刊>World Journal of Gastroenterology >Mechanisms and significance of liver steatosis in hepatitis C virus infection.
【24h】

Mechanisms and significance of liver steatosis in hepatitis C virus infection.

机译:丙型肝炎病毒感染中肝脂肪变性的机制和意义。

获取原文
获取原文并翻译 | 示例
           

摘要

The pathogenesis of liver damage associated with chronic hepatitis C virus (HCV) infection is thought to be largely immunomediated. However, some frequent histopathological features, such as steatosis, suggest a direct cytopathic effect of HCV. The direct responsibility of HCV in the pathogenesis of steatosis is shown by: (1) the association with HCV genotype 3 infection, suggesting that some viral sequences are involved in the intracellular accumulation of lipids; (2) the correlation between severity of steatosis and HCV replication levels; (3) association between response to treatment and disappearance of steatosis. Experimental studies have shown that the nucleocapsid protein of HCV (core protein) is capable and sufficient to induce lipid accumulation in hepatocytes. Moreover, the observation that chronic hepatitis C patients have reduced serum levels of ApoB suggests an interference with the very-low density lipoprotein (VLDL) assembly, although other mechanisms are possible. In patients with sustained virological response induced by antiviral therapy, such levels are normalized. Other observations suggest that the pathogenesis of steatosis in chronic hepatitis C is not solely due to HCV. The origin of the mild steatosis observed in most patients may be metabolic, since its severity correlates with body mass index and insulin resistance. Most studies have shown a correlation between presence and/or severity of steatosis and fibrosis stage, but it is unclear whether this effect is direct or mediated by the associated insulin resistance, increased susceptibility to apoptosis, or by inflammatory cytokines. Finally, steatosis negatively influences the rate of response to antiviral treatment, as confirmed by large clinical trials. Management of steatosis in chronic hepatitis C requires knowledge of its pathogenesis and may involve both life-style changes and pharmacological interventions, although the latter remain largely experimental.
机译:与慢性丙型肝炎病毒(HCV)感染相关的肝损伤的发病机理被认为主要是免疫介导的。但是,一些常见的组织病理学特征(例如脂肪变性)提示HCV具有直接的细胞病变作用。 HCV在脂肪变性的发病机制中的直接责任表现为:(1)与HCV基因型3感染的相关性,表明某些病毒序列参与脂质的细胞内积累; (2)脂肪变性严重程度与HCV复制水平之间的相关性; (3)治疗反应与脂肪变性消失之间的关联。实验研究表明,HCV的核衣壳蛋白(核心蛋白)能够并且足够诱导脂质在肝细胞中的蓄积。此外,关于慢性丙型肝炎患者血清ApoB水平降低的观察表明,尽管其他机制也是可能的,但干扰了极低密度脂蛋白(VLDL)的装配。在由抗病毒治疗引起的持续病毒学应答的患者中,将这些水平标准化。其他观察结果表明,慢性丙型肝炎脂肪变性的发病机理不仅是由于HCV引起的。在大多数患者中观察到的轻度脂肪变性的起源可能是代谢性的,因为其严重程度与体重指数和胰岛素抵抗相关。大多数研究表明脂肪变性和纤维化阶段的存在和/或严重程度之间存在相关性,但尚不清楚这种作用是直接的还是由相关的胰岛素抵抗,对细胞凋亡的敏感性增加或由炎性细胞因子介导的。最后,大型临床试验证实,脂肪变性会对抗病毒治疗的反应率产生负面影响。慢性丙型肝炎中脂肪变性的处理需要了解其发病机理,并且可能涉及生活方式的改变和药物干预,尽管后者仍主要是实验性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号